share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  04/03 23:12
牛牛AI助手已提取核心信息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 65,000 Class A shares on 04/03/2024, with an aggregate market value of $574,600. The shares to be sold were acquired through various means, including founders shares received on 09/01/2016, restricted stock vesting on 05/15/2023, and stock option exercises on 06/07/2023 and 07/12/2023. The securities were originally acquired as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 230,444 shares were sold for gross proceeds of $2,351,497.24. The notice of the upcoming sale was given in accordance with a plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 65,000 Class A shares on 04/03/2024, with an aggregate market value of $574,600. The shares to be sold were acquired through various means, including founders shares received on 09/01/2016, restricted stock vesting on 05/15/2023, and stock option exercises on 06/07/2023 and 07/12/2023. The securities were originally acquired as compensation or through cash payments. This planned sale follows a series of transactions over the past three months, where a total of 230,444 shares were sold for gross proceeds of $2,351,497.24. The notice of the upcoming sale was given in accordance with a plan adopted on 12/27/2023.
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定于2024年3月4日出售65,000股A类股票,总市值为574,600美元。待售股票是通过各种方式收购的,包括创始人于2016年1月9日获得的股票、2023年5月15日的限制性股票归属以及2023年7月6日和2023年12月7日行使股票期权。这些证券最初是作为补偿或通过现金支付获得的。此次计划出售是在过去三个月进行的一系列交易之后进行的,共出售了230,444股股票,总收益为2,351,497.24美元。即将进行的出售通知是根据2023年12月27日通过的计划发出的。
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定于2024年3月4日出售65,000股A类股票,总市值为574,600美元。待售股票是通过各种方式收购的,包括创始人于2016年1月9日获得的股票、2023年5月15日的限制性股票归属以及2023年7月6日和2023年12月7日行使股票期权。这些证券最初是作为补偿或通过现金支付获得的。此次计划出售是在过去三个月进行的一系列交易之后进行的,共出售了230,444股股票,总收益为2,351,497.24美元。即将进行的出售通知是根据2023年12月27日通过的计划发出的。

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成,只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。